GMT Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-69,774
Closed -$2.69M 95
2017
Q1
$2.69M Sell
69,774
-1,727,100
-96% -$52M 0.06% 95
2016
Q4
$39.7M Sell
1,796,874
-4,074,520
-69% -$83.6M 0.83% 39
2016
Q3
$93.9M Sell
5,871,394
-2,638,274
-31% -$30.1M 1.92% 11
2016
Q2
$70.1M Sell
8,509,668
-319,962
-4% -$2.85M 1.7% 15
2016
Q1
$61.8M Buy
8,829,630
+415,700
+5% +$2.09M 1.52% 20
2015
Q4
$45.1M Buy
8,413,930
+3,632,700
+76% +$23.2M 1.16% 26
2015
Q3
$44.9M Buy
+4,781,230
New +$50M 1.14% 25

Other funds holding CC

GMT Capital's CC Position: Q2 2017 in Review

GMT Capital sold out of Chemours (CC) in Q2 2017, closing a stake of 69,774 shares — an estimated $2.69M sold.

GMT Capital first reported a position in CC in Q3 2015 and held it in 7 quarters. The position peaked at $93.9M in Q3 2016. 462 funds tracked by Wall St. Rank hold CC as of Q2 2017.

  • GMT Capital reported no remaining Chemours position as of Q2 2017 after selling out during the quarter.
  • GMT Capital sold 69,774 Chemours shares in Q2 2017, an estimated $2.69M.
  • GMT Capital first reported a position in Chemours in Q3 2015 and held it in 7 quarters.
  • GMT Capital's Chemours position peaked at $93.9M in Q3 2016.
  • 462 funds tracked by Wall St. Rank held Chemours as of Q2 2017.

Based on GMT Capital's 13F filing for Q2 2017, filed 14 Aug 2017.